BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,013 | -17.6% | 7,764 | -0.5% | 0.02% | -15.8% |
| Q2 2023 | $355,505 | +15.4% | 7,803 | +2.8% | 0.02% | 0.0% |
| Q1 2023 | $308,013 | -30.4% | 7,594 | -12.5% | 0.02% | -34.5% |
| Q4 2022 | $442,267 | +6.1% | 8,677 | +12.0% | 0.03% | -3.3% |
| Q3 2022 | $417,000 | -22.1% | 7,747 | -7.0% | 0.03% | -11.8% |
| Q2 2022 | $535,000 | -25.6% | 8,329 | -10.2% | 0.03% | +13.3% |
| Q1 2022 | $719,000 | -17.7% | 9,271 | -8.9% | 0.03% | +3.4% |
| Q4 2021 | $874,000 | +10.4% | 10,178 | +3.3% | 0.03% | +7.4% |
| Q3 2021 | $792,000 | -0.1% | 9,849 | +0.1% | 0.03% | 0.0% |
| Q2 2021 | $793,000 | -4.3% | 9,844 | +0.2% | 0.03% | -15.6% |
| Q1 2021 | $829,000 | -1.3% | 9,825 | -6.2% | 0.03% | -13.5% |
| Q4 2020 | $840,000 | -7.0% | 10,473 | -6.7% | 0.04% | -19.6% |
| Q3 2020 | $903,000 | -25.7% | 11,229 | -20.5% | 0.05% | -32.4% |
| Q2 2020 | $1,215,000 | +38.1% | 14,116 | +30.2% | 0.07% | +3.0% |
| Q1 2020 | $880,000 | -27.2% | 10,839 | -25.0% | 0.07% | +24.5% |
| Q4 2019 | $1,208,000 | +6.0% | 14,450 | +10.9% | 0.05% | -8.6% |
| Q3 2019 | $1,140,000 | +0.7% | 13,030 | -5.8% | 0.06% | +7.4% |
| Q2 2019 | $1,132,000 | -18.1% | 13,826 | -18.7% | 0.05% | -18.2% |
| Q1 2019 | $1,382,000 | +29.4% | 16,996 | +4.7% | 0.07% | 0.0% |
| Q4 2018 | $1,068,000 | -31.9% | 16,228 | -20.3% | 0.07% | +10.0% |
| Q3 2018 | $1,569,000 | +42.1% | 20,354 | +36.2% | 0.06% | +36.4% |
| Q2 2018 | $1,104,000 | +1.7% | 14,945 | -10.5% | 0.04% | +2.3% |
| Q1 2018 | $1,086,000 | -4.7% | 16,703 | -5.3% | 0.04% | -2.3% |
| Q4 2017 | $1,140,000 | -20.6% | 17,634 | -22.9% | 0.04% | -26.7% |
| Q3 2017 | $1,436,000 | +17.8% | 22,885 | +13.6% | 0.06% | +9.1% |
| Q2 2017 | $1,219,000 | +20.8% | 20,142 | +3.5% | 0.06% | +22.2% |
| Q1 2017 | $1,009,000 | +23.8% | 19,465 | +5.9% | 0.04% | +18.4% |
| Q4 2016 | $815,000 | -9.2% | 18,378 | -2.6% | 0.04% | -11.6% |
| Q3 2016 | $898,000 | -13.6% | 18,872 | -17.9% | 0.04% | -15.7% |
| Q2 2016 | $1,039,000 | -0.4% | 22,976 | -9.5% | 0.05% | -5.6% |
| Q1 2016 | $1,043,000 | -4.8% | 25,378 | -11.7% | 0.05% | +3.8% |
| Q4 2015 | $1,096,000 | -1.8% | 28,733 | -15.4% | 0.05% | -18.8% |
| Q3 2015 | $1,116,000 | -64.3% | 33,962 | -24.0% | 0.06% | -50.4% |
| Q2 2015 | $3,125,000 | +10.3% | 44,694 | +8.1% | 0.13% | +17.3% |
| Q1 2015 | $2,832,000 | -4.1% | 41,349 | +2.7% | 0.11% | -9.1% |
| Q4 2014 | $2,952,000 | +22.3% | 40,272 | +19.8% | 0.12% | +7.1% |
| Q3 2014 | $2,413,000 | +18.9% | 33,616 | +19.7% | 0.11% | +27.0% |
| Q2 2014 | $2,030,000 | -15.6% | 28,078 | -14.1% | 0.09% | -18.3% |
| Q1 2014 | $2,404,000 | +24.2% | 32,675 | +17.4% | 0.11% | +25.3% |
| Q4 2013 | $1,936,000 | +11.1% | 27,836 | +5.0% | 0.09% | -5.4% |
| Q3 2013 | $1,742,000 | +2.6% | 26,515 | +8.2% | 0.09% | -23.3% |
| Q2 2013 | $1,698,000 | – | 24,514 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |